Maternal Health, Pregnant Women
Conditions
Keywords
Digital
Brief summary
The goal of this clinical trial is to test a behavioral intervention in pregnant women who identify as Black and live in Central Brooklyn. The main question it aims to answer is whether the WeCAB intervention leads to a net improvement in utilization of postpartum care compared to those receiving usual care. The WeCAB group will have a dedicated WeCAB community health worker who will be trained in digital care navigation. Researchers will compare the WeCAB group versus the group receiving usual care to see if the patients randomized to WeCAB will have higher rates of early post-partum care compared to patients in the control group.
Interventions
BEHAVIORALWeCAB Intervention
The WeCAB intervention will use a dedicated WeCAB community health worker who will administer a social determinants of health (SDOH) tool and use digital care navigation to monitor closed loop referrals.
Sponsors
State University of New York - Downstate Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No
Inclusion criteria
* Eligible participants for the pilot RCT will be patients * aged 18-49 years (childbearing age) * residing in a Central Brooklyn zip code * self-reporting as Black, * who speak English or Haitian Creole, and * plan to deliver or present for delivery at University Hospital at Downstate (UHD). * In NYC, SMM increases incrementally with later entry into prenatal care (1st trimester: 208/10,000 deliveries; 2nd trimester: 252/10,000; 3rd trimester: 297/10,000; None: 575/10,000). 3 Accordingly, in order to capture the full range of SMM risk profiles for our pilot study, any pregnant patient/client visiting our clinics will be eligible for enrollment from 13 weeks gestation through delivery, thus allowing follow-up to 3 months post-partum within the 2-year study timeline.
Exclusion criteria
* Patients planning to move outside of New York City in the ensuing 3 months post-partum * Patients demonstrating an impairment that limits their ability to provide informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Initiation of postpartum care | 13 weeks until 3 months postpartum | Initiation of postpartum care within 6 weeks of delivery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Maternal death | 13 weeks until 3 weeks postpartum | Death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes. |
Countries
United States
Contacts
Primary ContactAimee Afable, PHD
Backup ContactSandra Bruening, MS
Outcome results
None listed